CIK 0001576885 · <br>Emerging growth company
Acumen Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ABOS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364108129
- Phone
- 617-344-4190
- Business address
- 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Porter Derrell Director | Option exercise | +13,040 | $1.07 | $14K | 48,540 |
| 2026-06-17 | Porter Derrell Director | Sale | −13,040 | $2.33 | $30K | 35,500 |
| 2026-06-17 | Porter Derrell Director | Option exercise · Stock Option (right to buy) | −13,040 | 0 | ||
| 2026-06-16 | Porter Derrell Director | Sale | −12,800 | $2.33 | $30K | 35,500 |
| 2026-06-15 | Porter Derrell Director | Option exercise | +6,460 | $1.07 | $7K | 54,760 |
| 2026-06-15 | Porter Derrell Director | Sale | −6,460 | $2.35 | $15K | 48,300 |
| 2026-06-15 | Porter Derrell Director | Option exercise · Stock Option (right to buy) | −6,460 | 13,040 | ||
| 2026-06-09 | Fountain Nathan B Director | Sale | −6,400 | $2.23 | $14K | 48,150 |
| 2026-06-03 | Fountain Nathan B Director | Grant or award | +35,500 | 54,550 | ||
| 2026-06-03 | Fountain Nathan B Director | Grant or award · Stock Option (right to buy) | +53,250 | 53,250 | ||
| 2026-06-03 | Drapkin Kimberlee C Director | Grant or award | +35,500 | 48,300 | ||
| 2026-06-03 | Drapkin Kimberlee C Director | Grant or award · Stock Option (right to buy) | +53,250 | 53,250 | ||
| 2026-06-03 | Stalfort John A III Director | Grant or award | +35,500 | 220,624 | ||
| 2026-06-03 | Stalfort John A III Director | Grant or award · Stock Option (right to buy) | +53,250 | 53,250 | ||
| 2026-06-03 | Porter Derrell Director | Grant or award | +35,500 | 48,300 | ||
| 2026-06-03 | Porter Derrell Director | Grant or award · Stock Option (right to buy) | +53,250 | 53,250 | ||
| 2026-06-03 | Ives Jeffrey L. Director | Grant or award | +35,500 | 48,300 | ||
| 2026-06-03 | Ives Jeffrey L. Director | Grant or award · Stock Option (right to buy) | +53,250 | 53,250 | ||
| 2026-06-03 | Golumbeski George Director | Grant or award | +35,500 | 35,500 | ||
| 2026-06-03 | Golumbeski George Director | Grant or award · Stock Option (right to buy) | +53,250 | 53,250 |
Page 1 of 10 · 190 trades